Does it lead and what ownership does it target?

No uniform lead or ownership target was published.

How does the decision process work?

The reviewed sources do not publish the complete investment-committee process.

a16z Bio + Health

Not publicly disclosed in reviewed sources · company-creation, seed, venture, growth · US, Global

a16z Bio + Health is an active vc investing at company-creation, seed, venture, growth across US, Global. Current capital evidence: Up to $500M Biotech Ecosystem Venture Fund alongside the broader Bio + Health franchise. Public founder access is the official intake at https://a16z.com/bio-health/; exact ownership and selection rates remain unknown unless stated below.

Tier 1bioa16z

Visit / pitch Official site Open in the live directory

Key facts

Fund size	Up to $500M Biotech Ecosystem Venture Fund alongside the broader Bio + Health franchise
Stage	company-creation, seed, venture, growth
Typical first check	Not publicly disclosed in reviewed sources
Sectors	bio, health, ai
Geography	US, Global
Status	unknown

Always confirm on the official page before applying — dates and terms change.

Background

Andreessen Horowitz's life sciences and healthcare fund. This 2026-08-10 pass verified the current official team, strategy or portfolio presence and separated published behavior from private fund mechanics.

How the application really works

Official founder intake: https://a16z.com/bio-health/

Tips

Lead with fit to company-creation / seed / venture / growth and US / Global.
Route to a named investor whose official remit matches the company; do not infer an email pattern.
Reference why the company fits the current capital mandate (Up to $500M Biotech Ecosystem Venture Fund alongside the broader Bio + Health franchise).

Watch out for

Outside the stated stage, sector or deployment geography.
Treating a media, LP or generic corporate contact as a founder pitch route.
Assuming unpublished check, ownership or decision-speed data is guaranteed.

Track record

Insitro — listed portfolio evidence; verify company-level outcome details before scoring an exit.
Devoted Health — listed portfolio evidence; verify company-level outcome details before scoring an exit.
BigHat Biosciences — listed portfolio evidence; verify company-level outcome details before scoring an exit.

No acceptance rate or funnel conversion was published in the reviewed official sources.

Investment thesis

Engineer biology and transform healthcare with technology.

How to reach them

Twitter/X: @a16z
Pitch submission form
Official founder intake: https://a16z.com/bio-health/

Notable portfolio

InsitroDevoted HealthBigHat Biosciences

Frequently asked questions

What stages does the fund target?: company-creation, seed, venture, growth
Where does it invest?: US, Global
What is the latest disclosed capital vehicle?: Up to $500M Biotech Ecosystem Venture Fund alongside the broader Bio + Health franchise
How can a founder reach the fund?: Official founder intake: https://a16z.com/bio-health/
Does it lead and what ownership does it target?: No uniform lead or ownership target was published.
How does the decision process work?: The reviewed sources do not publish the complete investment-committee process.

Related venture funds

Andreessen Horowitz (a16z)Not publicly disclosed in the reviewed sources. · US, Global a16z cryptoNot publicly disclosed in reviewed sources · Global a16z American DynamismNot publicly disclosed in reviewed sources · US KaszekNot publicly disclosed in reviewed sources · Latin America Balderton CapitalNot publicly disclosed in reviewed sources · Europe AtomicoNot publicly disclosed in reviewed sources · Europe

Sources

a16z.com/announcement-andreessen-horowitz-partners-with-lilly-to-launch-first-of-its-kind-biotech-ecosystem-venture-fund — Capital, strategy or current activity evidence. (checked 2026-08-10)
a16z.com/bio-health — Official team and investing-person evidence. (checked 2026-08-10)
a16z.com/investment-list — Official portfolio and track-record evidence. (checked 2026-08-10)